Vamorolone is primarily used in the treatment of Duchenne muscular dystrophy (DMD), a genetic disorder characterized by progressive muscle degeneration. It functions as a dissociative anti-inflammatory steroid, offering similar anti-inflammatory benefits as traditional corticosteroids but with potentially fewer side effects. This makes it a promising option for managing inflammation and muscle weakness in DMD patients. Additionally, it is being studied for its potential in other inflammatory and muscle-related conditions, aiming to improve quality of life and slow disease progression.